Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 171

Similar articles for PubMed (Select 12242086)

1.

Several delta-opioid receptor ligands display no subtype selectivity to the human delta-opioid receptor.

Parkhill AL, Bidlack JM.

Eur J Pharmacol. 2002 Sep 20;451(3):257-64.

PMID:
12242086
2.

Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor.

Clark MJ, Emmerson PJ, Mansour A, Akil H, Woods JH, Portoghese PS, Remmers AE, Medzihradsky F.

J Pharmacol Exp Ther. 1997 Nov;283(2):501-10.

4.
5.

A comprehensive study on the putative δ-opioid receptor (sub)types using the highly selective δ-antagonist, Tyr-Tic-(2S,3R)-β-MePhe-Phe-OH.

Birkas E, Bakota L, Gulya K, Wen T, Pintar J, Tóth G, Szucs M.

Neurochem Int. 2011 Aug;59(2):192-201. doi: 10.1016/j.neuint.2011.04.015. Epub 2011 Jun 6.

PMID:
21672586
6.
7.

Evaluation of a series of N-alkyl benzomorphans in cell lines expressing transfected delta- and mu-opioid receptors.

Abood ME, Noel MA, Carter RC, Harris LS.

Biochem Pharmacol. 1995 Sep 7;50(6):851-9.

PMID:
7575648
8.

Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.

Ioja E, Tourwé D, Kertész I, Tóth G, Borsodi A, Benyhe S.

Brain Res Bull. 2007 Sep 14;74(1-3):119-29. Epub 2007 Jun 8.

PMID:
17683797
9.

Opioid peptide receptor studies. 8. One of the mouse brain deltaNCX binding sites is similar to the cloned mouse opioid delta receptor: further evidence for heterogeneity of delta opioid receptors.

Xu H, Lu YF, Partilla JS, Pinto J, Calderon SN, Matecka D, Rice KC, Lai J, Porreca F, Ananthan S, Rothman RB.

Peptides. 1998;19(2):343-50.

PMID:
9493867
10.

Bioactivity of new mu and delta opioid peptides.

Capasso A.

Med Chem. 2007 Sep;3(5):480-7.

PMID:
17897075
11.
13.

Characterization of specific opioid binding sites in neural membranes from the myenteric plexus of porcine small intestine.

Townsend D 4th, Portoghese PS, Brown DR.

J Pharmacol Exp Ther. 2004 Jan;308(1):385-93. Epub 2003 Oct 20.

14.
15.

Involvement of delta 1-opioid receptor antagonism in the antitussive effect of delta-opioid receptor antagonists.

Kamei J, Iwamoto Y, Suzuki T, Misawa M, Nagase H, Kasuya Y.

Eur J Pharmacol. 1994 Jan 14;251(2-3):291-4.

PMID:
8149982
16.

Mutation W284L of the human delta opioid receptor reveals agonist specific receptor conformations for G protein activation.

Hosohata Y, Varga EV, Stropova D, Li X, Knapp RJ, Hruby VJ, Rice KC, Nagase H, Roeske WR, Yamamura HI.

Life Sci. 2001 Apr 6;68(19-20):2233-42.

PMID:
11358332
17.

Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.

Hirose N, Murakawa K, Takada K, Oi Y, Suzuki T, Nagase H, Cools AR, Koshikawa N.

Neuroscience. 2005;135(1):213-25.

PMID:
16111831
18.

Characterization of specific delta-opioid binding sites in the distal small intestine of swine.

Townsend D 4th, Brown DR.

Eur J Pharmacol. 2003 Dec 15;482(1-3):111-6.

PMID:
14660011
19.

Selective in vivo binding of [3H]naltriben to delta-opioid receptors in mouse brain.

Lever JR, Scheffel U.

Eur J Pharmacol. 1998 Jun 5;350(2-3):335-44.

PMID:
9696425
20.

Analysis of delta-opioid receptor activities stably expressed in CHO cell lines: function of receptor density?

Law PY, McGinn TM, Wick MJ, Erikson LJ, Evans C, Loh HH.

J Pharmacol Exp Ther. 1994 Dec;271(3):1686-94.

PMID:
7996485
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk